Senti Biosciences

Senti Biosciences (Nasdaq: SNTI) is a clinical-stage biotechnology company based in South San Francisco, California that engineers programmable "Gene Circuits" into cell and gene therapies to treat cancer with greater precision and control. Its lead candidate, SENTI-202, is an off-the-shelf logic-gated CAR NK cell therapy in clinical trials for acute myeloid leukemia and other hematologic malignancies. The company was surfaced as a portfolio company of lux-capital and menlo-ventures. As a therapeutics company it exposes no public developer API, SDK, or documentation surface; this profile captures its identity and probed domain-security posture.

Senti Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotech, Biotechnology, Cell and Gene Therapy, and Gene Circuits.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechBiotechnologyCell and Gene TherapyGene CircuitsOncologyTherapeuticsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/senti-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Senti Biosciences Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 3

The organization behind the API

Website
Website
 InvestorRelations
InvestorRelations
 Careers
Careers

Source (apis.yml)

apis.yml Raw ↑ 
aid: senti-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/senti-biosciences.png
name: Senti Biosciences
description: 'Senti Biosciences (Nasdaq: SNTI) is a clinical-stage biotechnology company based in South San Francisco, California
  that engineers programmable "Gene Circuits" into cell and gene therapies to treat cancer with greater precision and control.
  Its lead candidate, SENTI-202, is an off-the-shelf logic-gated CAR NK cell therapy in clinical trials for acute myeloid
  leukemia and other hematologic malignancies. The company was surfaced as a portfolio company of lux-capital and menlo-ventures.
  As a therapeutics company it exposes no public developer API, SDK, or documentation surface; this profile captures its identity
  and probed domain-security posture.'
url: https://raw.githubusercontent.com/api-evangelist/senti-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lux-capital
- menlo-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotech
- Biotechnology
- Cell and Gene Therapy
- Gene Circuits
- Oncology
- Therapeutics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/senti-biosciences-domain-security.yml
- type: Website
  url: https://www.sentibio.com
- type: InvestorRelations
  url: https://investors.sentibio.com/
- type: Careers
  url: https://careers.sentibio.com/
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1